Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR flucytosine versus immediate-release flucytosine in HIV-associated cryptococcal meningitis
ISRCTN26737196Phase 2Active, not recruiting
- Sponsor
- Drugs for Neglected Diseases initiative
- Start
- Feb 2025
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of flucytosine in cryptococcal meningitis (2 arms), sponsored by Drugs for Neglected Diseases initiative. Started Feb 2025; status: active, not recruiting.
02
Drugs
flucytosine
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on ISRCTN26737196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26737196.